Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hugo

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 29, 2023
Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patientsMarianne Graninger, Julian Stumpf, Gregor Bond, et al.
Transplantation Proceedings|February 21, 2021
Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO)Christian Hugo, Horst Weihprecht, Bernhard Banas, et al.
Plos One|February 27, 2013
The mitogen-activated protein kinase p38α regulates tubular damage in murine anti-glomerular basement membrane nephritisRalf Müller, Christoph Daniel, Christian Hugo, et al.
Cellular Signalling|June 7, 2019
New automatic quantification method of immunofluorescence and histochemistry in whole histological sectionsFriederike Kessel, Anne Steglich, Todor Tschongov, et al.
Journal of Neurology|August 25, 2023
Identification of patients at high risk for brain death using an automated digital screening tool: a prospective diagnostic accuracy studyDaniela Schoene, Norman Freigang, Anne Trabitzsch, et al.
Kidney International|April 28, 2019
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patientsClaudia Sommerer, Barbara Suwelack, Duska Dragun, et al.
The Journal of Clinical Investigation|December 17, 2013
Complement factor H-related hybrid protein deregulates complement in dense deposit diseaseQian Chen, Michael Wiesener, Hannes U Eberhardt, et al.
Transplantation|August 3, 2021
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney TransplantJulian Stumpf, Wulf Tonnus, Alexander Paliege, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 11, 2012
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantationMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Kidney International|July 10, 2017
Persistent and inducible neogenesis repopulates progenitor renin lineage cells in the kidneyLinda Hickmann, Anne Steglich, Michael Gerlach, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 29, 2023
Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patientsMarianne Graninger, Julian Stumpf, Gregor Bond, et al.
Transplantation Proceedings|February 21, 2021
Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO)Christian Hugo, Horst Weihprecht, Bernhard Banas, et al.
Plos One|February 27, 2013
The mitogen-activated protein kinase p38α regulates tubular damage in murine anti-glomerular basement membrane nephritisRalf Müller, Christoph Daniel, Christian Hugo, et al.
Cellular Signalling|June 7, 2019
New automatic quantification method of immunofluorescence and histochemistry in whole histological sectionsFriederike Kessel, Anne Steglich, Todor Tschongov, et al.
Journal of Neurology|August 25, 2023
Identification of patients at high risk for brain death using an automated digital screening tool: a prospective diagnostic accuracy studyDaniela Schoene, Norman Freigang, Anne Trabitzsch, et al.
Kidney International|April 28, 2019
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patientsClaudia Sommerer, Barbara Suwelack, Duska Dragun, et al.
The Journal of Clinical Investigation|December 17, 2013
Complement factor H-related hybrid protein deregulates complement in dense deposit diseaseQian Chen, Michael Wiesener, Hannes U Eberhardt, et al.
Transplantation|August 3, 2021
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney TransplantJulian Stumpf, Wulf Tonnus, Alexander Paliege, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 11, 2012
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantationMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Kidney International|July 10, 2017
Persistent and inducible neogenesis repopulates progenitor renin lineage cells in the kidneyLinda Hickmann, Anne Steglich, Michael Gerlach, et al.
Pageof 14